title: Theory and applications of covalent docking in drug discovery: merits and pitfalls.
abstract: he present art of drug discovery and design of new drugs is based on suicidal irreversible inhibitors. Covalent inhibition is the strategy that is used to achieve irreversible inhibition. Irreversible inhibitors interact with their targets in a time-dependent fashion, and the reaction proceeds to completion rather than to equilibrium. Covalent inhibitors possessed some significant advantages over non-covalent inhibitors such as covalent warheads can target rare, non-conserved residue of a particular target protein and thus led to development of highly selective inhibitors, covalent inhibitors can be effective in targeting proteins with shallow binding cleavage which will led to development of novel inhibitors with increased potency than non-covalent inhibitors. Several computational approaches have been developed to simulate covalent interactions; however, this is still a challenging area to explore. Covalent molecular docking has been recently implemented in the computer-aided drug design workflows to describe covalent interactions between inhibitors and biological targets. In this review we highlight: (i) covalent interactions in biomolecular systems; (ii) the mathematical framework of covalent molecular docking; (iii) implementation of covalent docking protocol in drug design workflows; (iv) applications covalent docking: case studies and (v) shortcomings and future perspectives of covalent docking. To the best of our knowledge; this review is the first account that highlights different aspects of covalent docking with its merits and pitfalls. We believe that the method and applications highlighted in this study will help future efforts towards the design of irreversible inhibitors.
authors: Molecular Modelling and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa. hezekiel1989@gmail.com.
authors: Hezekiel Mathambo
authors: HM
authors: Kumalo
authors: Molecular Modelling and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa. bhakatsoumendranath@gmail.com.
authors: Soumendranath
authors: S
authors: Bhakat
authors: Molecular Modelling and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Westville, Durban 4000, South Africa. soliman@ukzn.ac.za.
authors: Mahmoud E S
authors: ME
authors: Soliman
mesh_terms: D055808:Drug Discovery; D006801:Humans; D062105:Molecular Docking Simulation; D011485:Protein Binding; D012984:Software; D013816:Thermodynamics
references: PLoS Comput Biol. 2012 May;8(5):e1002499
references: 22693435
references: J Med Chem. 2006 Oct 19;49(21):6177-96
references: 17034125
references: Comb Chem High Throughput Screen. 2011 Jul;14(6):500-20
references: 21521152
references: J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S146-9
references: 18520300
references: Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1035-52
references: 18680439
references: Expert Opin Drug Discov. 2012 Jul;7(7):561-81
references: 22607458
references: Wiley Interdiscip Rev Syst Biol Med. 2013 Sep-Oct;5(5):523-38
references: 23757159
references: J Cell Mol Med. 2009 Feb;13(2):238-48
references: 19183238
references: Expert Opin Drug Metab Toxicol. 2010 Jul;6(7):835-49
references: 20465522
references: J Mol Recognit. 2011 Mar-Apr;24(2):149-64
references: 21360606
references: J Med Chem. 2009 Mar 12;52(5):1231-46
references: 19203292
references: Proc Natl Acad Sci U S A. 1975 Aug;72(8):3073-6
references: 810797
references: J Comput Chem. 2009 Dec;30(16):2785-91
references: 19399780
references: Curr Opin Drug Discov Devel. 2004 Jan;7(1):126-36
references: 14982156
references: Nat Rev Drug Discov. 2011 Apr;10(4):307-17
references: 21455239
references: J Mol Biol. 1997 Apr 4;267(3):727-48
references: 9126849
references: J Med Chem. 2005 Feb 24;48(4):1107-31
references: 15715478
references: J Comput Chem. 2013 Feb 5;34(4):326-36
references: 23034731
references: Int J Obes Relat Metab Disord. 1997 Jun;21 Suppl 3:S12-23
references: 9225172
references: Curr Top Med Chem. 2014;14(16):1875-89
references: 25262796
references: Biochem J. 1988 Dec 1;256(2):357-61
references: 3223916
references: Chem Rev. 2014 Jan 8;114(1):493-537
references: 24024775
references: J Mol Recognit. 2013 May;26(5):215-39
references: 23526775
references: Expert Opin Drug Discov. 2010 Nov;5(11):1047-65
references: 22827744
references: J Biol Chem. 1994 May 6;269(18):13207-15
references: 8175750
references: J Chem Inf Model. 2014 Jun 23;54(6):1687-99
references: 24802635
references: Biochemistry (Mosc). 2010 Dec;75(12):1444-9
references: 21314614
references: Curr Opin Struct Biol. 2007 Dec;17(6):674-9
references: 17884461
references: J Med Chem. 2009 Nov 12;52(21):6672-84
references: 19888757
references: BMC Struct Biol. 2009 Jun 03;9:39
references: 19493341
references: J Mol Biol. 1994 Jan 21;235(3):983-1002
references: 8289329
references: FASEB J. 1989 Sep;3(11):2294-7
references: 2506093
references: J Chem Inf Model. 2014 Jul 28;54(7):1932-40
references: 24916536
references: Biopolymers. 2001;60(2):124-33
references: 11455546
references: Arch Pharm (Weinheim). 2008 Aug;341(8):465-77
references: 18493974
references: J Cheminform. 2009 Sep 11;1:15
references: 20150996
references: Expert Opin Drug Discov. 2010 Jun 1;5(6):597-607
references: 21532931
references: J Chem Inf Model. 2014 Jul 28;54(7):1941-50
references: 24932913
references: Chem Res Toxicol. 2013 Nov 18;26(11):1739-45
references: 24164572
references: ACS Chem Biol. 2013 Jan 18;8(1):82-95
references: 23259582
references: J Chem Inf Model. 2012 Oct 22;52(10):2697-704
references: 23005250
references: J Med Chem. 2009 Jan 22;52(2):225-33
references: 19053779
references: Drug Metab Rev. 2005;37(1):41-213
references: 15747500
references: J Comput Chem. 2010 Jan 30;31(2):455-61
references: 19499576
references: Proteins. 2014 Aug;82(8):1646-55
references: 24619874
references: J Chem Inf Model. 2009 Aug;49(8):1963-73
references: 19610597
references: J Med Chem. 2013 Feb 28;56(4):1478-90
references: 23350811
references: J Mol Biol. 1996 Aug 23;261(3):470-89
references: 8780787
references: Biochemistry. 1992 Oct 13;31(40):9520-5
references: 1390734
references: J Med Chem. 2007 Feb 22;50(4):726-41
references: 17300160
references: Bioorg Med Chem. 2012 Nov 1;20(21):6313-20
references: 23026084
references: J Mol Model. 2009 Dec;15(12):1481-90
references: 19440739
references: Biochemistry. 2005 Apr 19;44(15):5561-71
references: 15823014
references: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2070-5
references: 18227510
references: Adv Drug Deliv Rev. 2013 May;65(5):607-21
references: 22664231
references: Molecules. 2011 Sep 05;16(9):7551-64
references: 21894088
references: J Med Chem. 2009 Sep 24;52(18):5712-20
references: 19719084
references: J Med Chem. 2010 Mar 11;53(5):1990-9
references: 20158184
references: J Med Chem. 2009 Jan 22;52(2):397-406
references: 19090659
references: J Comput Aided Mol Des. 2007 Oct-Nov;21(10-11):549-58
references: 17960327
references: Pharmacoeconomics. 2001;19(3):303-18
references: 11303418